Skip to content

72 hours Moisturization Activity of Nat Habit Multiple Moisturizers

A clinical study to evaluate the 72 hours Moisturization Potential of Nat Habit Multiple Moisturizers on healthy human volunteers - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/104861
Enrollment
32
Registered
2026-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: 1.Active Orange Kiwi Vit-C Gel Moisturiser 2.Malai Moisturiser - Above 35Yrs-Flax Bakuchi Vit-EC Omega+ 3.Malai Moisturiser - 20-35Yrs- Tomato Rosehip Vit-BEC Youth Anchor

Sponsors

Naturohabit Private Limited (NAT HABIT)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Gender: Male or Female with age 18-45. 2) Subject with normal skin. 3) Subjects willing to give written informed consent. 4) Women of child bearing potential must have a negative urine. pregnancy test prior to study entry. 5) Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 6) Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study. 2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last years, or any other confounding skin condition. 3. Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product. 4. Have participated in any interventional clinical trial in the previous 90 days. 5. Have a known sensitivity to any of the constituents of the test product 6. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids

Design outcomes

Primary

MeasureTime frame
Change in hydration Change in TEWLTimepoint: T0min, T30min, T+2hrs, T+8hrs, T+24hrs, T+ 48hours, T+72hrs

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026